UnitedHealth Group Incorporated $UNH Stock Bought by Factory Mutual Insurance Co.

Factory Mutual Insurance Co. raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% during the third quarter, Holdings Channel.com reports. The firm owned 273,616 shares of the healthcare conglomerate’s stock after purchasing an additional 11,466 shares during the period. UnitedHealth Group makes up 0.9% of Factory Mutual Insurance Co.’s holdings, making the stock its 27th biggest holding. Factory Mutual Insurance Co.’s holdings in UnitedHealth Group were worth $100,439,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Corient Private Wealth LP acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth about $245,516,000. Legal & General Group Plc acquired a new position in UnitedHealth Group in the second quarter valued at about $2,444,928,000. Jupiter Topco LLC acquired a new position in UnitedHealth Group in the second quarter valued at about $2,019,844,000. BlackRock Inc. boosted its stake in UnitedHealth Group by 4.6% during the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after buying an additional 3,395,530 shares during the period. Finally, Canada Pension Plan Investment Board acquired a new stake in shares of UnitedHealth Group during the second quarter valued at about $971,757,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on UNH. Evercore boosted their price target on shares of UnitedHealth Group from $400.00 to $480.00 and gave the company an “outperform” rating in a research note on Tuesday, July 7th. Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $370.00 to $467.00 and gave the company a “hold” rating in a research report on Friday, July 17th. Robert W. Baird decreased their price target on UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 14th. New Street Research set a $402.00 price target on UnitedHealth Group in a research report on Friday, October 9th. Finally, UBS Group reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research note on Tuesday, October 13th. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $463.93.

UnitedHealth Group Trading Up 0.7%

NYSE UNH opened at $403.10 on Wednesday. The firm has a 50 day simple moving average of $390.47 and a 200-day simple moving average of $363.08. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The firm has a market cap of $361.81 billion, a price-to-earnings ratio of 23.02, a PEG ratio of 1.45 and a beta of 0.51.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm had revenue of $112.72 billion during the quarter, compared to analysts’ expectations of $111.31 billion. During the same quarter in the previous year, the business posted $2.59 earnings per share. The business’s quarterly revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s payout ratio is presently 53.00%.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Earnings and outlook are key tailwinds. UnitedHealth’s quarterly EPS and revenue beat analysts’ estimates, and the company raised its 2026 profit outlook. Those results helped drive an approximately 11% share gain over the month through October 30. UnitedHealth Just Gained 11% in a Month: Take Profits, or Buy More?
• Positive Sentiment: Buying and value-oriented endorsements provide support. ETFs recorded net purchases of UnitedHealth shares, including $35 million in buying on October 29. BetterInvesting Magazine also named UNH its “Undervalued Stock,” though such selections are not a guarantee of future performance. UnitedHealth Group Draws ETF Buying BetterInvesting Magazine Update
• Neutral Sentiment: Optum Insight’s AI investment is a longer-term opportunity with execution risk. UnitedHealth is expanding AI tools to improve efficiency and claims processing, but rising costs mean the spending still needs to translate into profit growth. Will UNH’s Optum Insight Spending Translate Into Profit Growth?
• Negative Sentiment: Political scrutiny could weigh on sentiment. Senator Elizabeth Warren criticized the Trump administration’s approval of UnitedHealth’s $3.3 billion Amedisys acquisition, arguing the deal increases the company’s power over costs and patient care. The comments renew attention to potential regulatory and political risks. Elizabeth Warren Criticizes UnitedHealth’s Amedisys Deal

UnitedHealth Group Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.